vTv Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,000 | $-9 |
Gross Profit | -23 | 978 | -32 | |
EBITDA | -5,818 | -6,386 | -5,605 | -4,411 |
EBIT | -5,840 | -6,409 | -5,627 | -4,434 |
Net Income | -4,783 | -5,180 | -4,865 | -3,478 |
Net Change In Cash | 0 | 0 | 1,000 | -9 |
Free Cash Flow | -6,418 | -6,729 | -7,335 | -2,914 |
Cash | 41,571 | 45,526 | 52,255 | 9,446 |
Basic Shares | 5,456 | 6,403 | 4,141 | 2,084 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $9 | $2,018 | $4,005 | $6,414 |
Gross Profit | -13,595 | 1,926 | 3,916 | -4,601 |
EBITDA | -25,412 | -24,766 | -17,515 | -12,016 |
EBIT | -25,502 | -24,858 | -17,604 | -12,110 |
Net Income | -20,250 | -25,073 | -17,731 | -8,827 |
Net Change In Cash | 9 | 2,018 | 4,005 | 6,414 |
Cost of Revenue | -1,289 | 1,470 | ||
Free Cash Flow | -19,081 | -16,043 | -19,308 | -18,000 |
Cash | 9,446 | 12,126 | 13,415 | 5,747 |
Basic Shares | 2,084 | 1,919 | 1,566 | 1,178 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.87 |
2024-06-30 | -$0.80 |
2024-03-31 | -$1.17 |
2023-12-31 | -$1.67 |
